⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Inflammasome Therapeutics just got measured.
4/10 means Inflammasome Therapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About Inflammasome Therapeutics
Inflammasome Therapeutics is a science-based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration and type 2 diabetes.
Details
Industry: Technology
inflam.comAI Visibility Breakdown
1
Structured Data
4
Content Structure
5
Entity Clarity
4
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Inflammasome Therapeutics.
Source & Attribution
Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/inflam
Cite this score: Engagemii (2026). "AEO Score for Inflammasome Therapeutics." Retrieved from https://engagemii.com/aeo/brands/inflam
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform